In the section titled, "Overall survival and Progression free survival" within the Results Section the value of overall survival of patients at 3 years was incorrectly described as 68.7%. The correct value is 40.6%.
Citation: Miwa S, Nishida H, Tanzawa Y, Takata M, Takeuchi A, Yamamoto N, et al. (2013) Correction: TNF-α and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors. PLoS ONE 8(10): 10.1371/annotation/7c0f14e6-cfba-4f5f-b93d-1a149eaeec96. https://doi.org/10.1371/annotation/7c0f14e6-cfba-4f5f-b93d-1a149eaeec96
Published: October 24, 2013
Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.